tiquizium

CAS No. 149755-23-7

tiquizium( —— )

Catalog No. M28946 CAS No. 149755-23-7

Tiquizium has effective Antimuscarinic effect, and causes significant bronchodilation in patients with chronic obstructive pulmonary disease.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 151 In Stock
5MG 149 In Stock
10MG 220 In Stock
25MG 337 In Stock
50MG 462 In Stock
100MG 619 In Stock
200MG 835 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    tiquizium
  • Note
    Research use only, not for human use.
  • Brief Description
    Tiquizium has effective Antimuscarinic effect, and causes significant bronchodilation in patients with chronic obstructive pulmonary disease.
  • Description
    Tiquizium has effective Antimuscarinic effect, and causes significant bronchodilation in patients with chronic obstructive pulmonary disease.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    AChR
  • Recptor
    EAAT2
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    149755-23-7
  • Formula Weight
    330.53
  • Molecular Formula
    C19H24NS2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C[N+](CCCC1)(C2)[C@H]1CCC2=C(c1cccs1)c1cccs1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Kortagere S, et al. Identification of Novel Allosteric Modulators of Glutamate Transporter EAAT2. ACS Chem Neurosci. 2018 Mar 21;9(3):522-534.
molnova catalog
related products
  • NS9283

    NS9283, a positive allosteric modulator selective for the α4β2 form, reduces ethanol consumption.

  • Otenzepad

    Otenzepad is a selective antagonist of M2 mAChR with IC50s of 386 nM and 640 nM for rat heart and rabbit peripheral lung.

  • Tolterodine

    Tolterodine ((R)-(+)-Tolterodine) is a novel and selective muscarinic-type receptor (mAChR) antagonist used in the treatment of detrusor instability and overactive bladder syndrome.